Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Study to Evaluate the Safety and Efficacy of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison With Paclitaxel and Carboplatin Against Anaplastic Thyroid Carcinoma [FACT]

NCT00507429 is registered in ClinicalTrials.gov with Mateon Therapeutics as lead sponsor.

NCT NCT00507429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00507429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Study to Evaluate the Safety and Efficacy of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison With Paclitaxel and Carboplatin Against Anaplastic Thyroid Carcinoma [FACT]
Lead sponsor
Mateon Therapeutics
Phase
Phase 2/3
Overall status
Terminated
Start date
August 31, 2007
Completion date
November 30, 2011
Enrollment
80 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic thyroid cancer